Posted on 7/9/18
Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC)
Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a strategic manufacturing and supply agreement . . .
Posted on 7/9/18
3 Top Biotech Stocks to Buy for the 2nd Half of 2018
It seemed almost like a blur, but the first half of 2018 is already history. Generally speaking, biotech stocks didn't perform as well during the first . . .
Posted on 7/8/18
Oramed Announces Closing of $18.1 Million Registered Direct Offering
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the closing of its previously-announced . . .
Posted on 7/6/18
Melinta Therapeutics: Could The H.R. 6294 Bill Improve The Prospects Of Antibiotic Innovators?
Life will have terrible blows in it, horrible blows, unfair blows. It doesn't matter. And some people recover and others don't. And there I think the . . .
Posted on 7/6/18
3 Best Biotech Acquisitions of 2018 (So Far)
If you expected 2018 to be a busy year for biotech mergers and acquisitions activity, you were right. There have already been several huge deals -- . . .
Posted on 7/5/18
Enzyvant Announces Collaboration with Visikol
Enzyvant, a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases, today announced that it has formed a partnership with Visikol, a contract . . .
Posted on 7/5/18
Phibro Animal Health to Establish New Biotech Facility in Sligo, Ireland, Creating Up To 150 Jobs
TEANECK, N.J., July 05, 2018 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced plans to establish a biotech facility producing a range of innovative . . .
Posted on 7/3/18
Henry Schein Partners with Special Olympics
Henry Schein, Inc. (Nasdaq: HSIC) today announced that it has formed a multi-year partnership with Special Olympics to support the organization's efforts to deliver health care . . .
Posted on 7/3/18
Soligenix Closes $8M At The Market Public Offering
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 7/3/18
CURE Media Group Expands Strategic Alliance Partnership Program with Lung Cancer Alliance
CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, welcomes Lung Cancer Alliance to its . . .
Posted on 7/2/18
Cantel Medical Announces Completion of Credit Agreement Refinancing
Cantel Medical Corp. (NYSE: CMD) today announced that it has completed a refinancing of its credit facility by amending the existing agreement to include a $200 . . .
Posted on 7/2/18
Nomad Health Launches Its Online Marketplace in the Midwest
NEW YORK--(BUSINESS WIRE)--Nomad Health, the first online marketplace connecting doctors and nurses with healthcare jobs, has launched its digital platform in the Midwestern United States today. . . .
Posted on 7/2/18
Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors
BUFFALO, N.Y., July 02, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for . . .
Posted on 7/2/18
Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics
If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm's share price . . .
Posted on 7/2/18
Better Buy: Amgen Inc. vs. Pfizer Inc.
Amgen Inc. (NASDAQ:AMGN) and Pfizer Inc. (NYSE:PFE) actually have quite a bit in common. They co-market one of the world's best-selling drugs, Enbrel. They both face . . .
Posted on 7/2/18
Celgene Investors Breathe a Sigh of Relief After Acceleron's Success
Celgene Corp. (NASDAQ:CELG) investors would probably like a few do-overs given the company's stumbles over the past year. First, it suffered a key clinical-trial failure that . . .
Posted on 7/2/18
Is Cara Therapeutics, Inc. a Buy?
It's been a very good week for Cara Therapeutics, Inc. (NASDAQ:CARA). The biotech stock soared after Cara reported positive results from a phase 2/3 clinical study . . .
Posted on 6/29/18
Bartle’s Pharmacy Receives McKesson’s Pharmacy of the Year Award
IRVING, Texas--(BUSINESS WIRE)--Bartle’s Pharmacy in Oxford, New York received McKesson’s Pharmacy of the Year Award. The Health Mart community pharmacy is being recognized for their superior . . .
Posted on 6/28/18
Soligenix Prices $8M Public Offering
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 6/28/18
CURE Magazine Seeks Nominations for 2018 MPN Heroes Recognition Program
CRANBURY, N.J.--(BUSINESS WIRE)--CURE magazine, the nation’s leading digital and print media enterprise focused on patients with cancer, cancer centers and advocacy groups, is accepting nominations for the . . .
Posted on 6/28/18
Cryptocurrency Research Launches on New Independent Research Platform
NEW YORK--(BUSINESS WIRE)--Analyst Hub, an independent research infrastructure platform company that provides sell-side analysts a path to owning their own enterprise, announced it has partnered with . . .
Posted on 6/28/18
Cara Therapeutics: Scratching An Itch Left Unscratched
Company Introduction And ThesisCara Therapeutics Inc. (CARA) is a small-cap biopharmaceutical company whose focus revolves around pruritus (severe itch) and pain, specifically through selective targeting and . . .
Posted on 6/28/18
Johnson & Johnson: A $144 Discounted Cash Flow Valuation
In this article, I will provide a discounted cash flow (NYSE:DCF) valuation for Johnson & Johnson (JNJ). I will first discuss Q1 results because it gives . . .
Posted on 6/27/18
Taglich Brothers Initiates Coverage of First Choice Healthcare Solutions
NEW YORK, June 27, 2018 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces that it has initiated coverage of First Choice Healthcare Solutions, Inc. (OTC:FCHS). First Choice . . .
Posted on 6/27/18
Novartis Announces Funding For Patient Advocacy Initiatives
Novartis today announced support for three US-based patient advocacy groups provided through the STEP (Solutions to Empower Patients) Program. The STEP Program is an initiative that . . .

